shingles vaccine

GSK Launches More Effective Shingles Vaccine
GSK Launches More Effective Shingles VaccineWill Shingrix become the new go-to shingles vaccine?
Shingles vaccine wins approvalFDA approved the herpes zoster vaccine (Shingrix, GlaxoSmithKline) to treat shingles in adults aged 50 years and older.
Formulary managers can help improve vaccination rates
Formulary managers can help improve vaccination ratesManaged care and hospital decision-makers are in a key position to “move the needle” at the system level on improving adult immunization coverage rates in the United States.
Low use of herpes zoster vaccine raises concernsOphthalmologists in support of routine vaccinations for herpes zoster (shingles) can take steps to offer their older patients more protection against the ocular complications of the disease.
Zoster vaccine effective in older chemotherapy patientsHerpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, a study published August 4 in Clinical Infectious Diseases.
Older adults with shingles experience more likely to ask for vaccinePersonal knowledge of or experience with shingles may be a major driver in a consumer's decision about whether to receive the shingles vaccine, according to a Harris Interactive consumer awareness survey sponsored by Merck.
Zoster vaccine effective but underused in elderly
Zoster vaccine effective but underused in elderlyZoster vaccination was associated with a reduction in post-herpetic neuralgia among those who are aged 65 and older, according to a study, published in PLoS Medicine. However, they also found that the use of the shingles vaccine was also very low among certain population groups